Effects of nicotine, pilocarpine, and tetrahydroaminoacridine on hippocampal theta waves in freely moving rabbits

European Journal of Pharmacology

Volumn 359, Issue 2-3, 1998, Pages 133-137

  Yamamoto, Jyunji ^a  

^a Pharmacological Research Laboratory   (Japan)

Author keywords

EEG power spectrum; Hippocampal theta wave; Nicotine; Pilocarpine; Rabbit, freely moving; Tetrahydroaminoacridine

Indexed keywords

CHOLINERGIC RECEPTOR STIMULATING AGENT; CHOLINESTERASE INHIBITOR; MUSCARINIC AGENT; NICOTINE; NICOTINIC AGENT; PILOCARPINE; TACRINE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; ELECTROCORTICOGRAPHY; HIPPOCAMPUS; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT; THETA RHYTHM;

EID: 0032561173     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(98)00685-2     Document Type: Article

References (14)

1. Bland B.H., Colom L.V. Responses of phasic and tonic hippocampal theta-on cells to cholinergics: differential effects of muscarinic and nicotinic activation. Brain Res. 440:1988;167-171.
2. Fisher, A., Heldman, E., Gurwitz, D., Haring, R., Karton, Y., Meshulam, H., Pittel, Z., Marciano, D., Marcovitch, I., Brandeis, R., 1994. Selective signaling via novel muscarinic agonists: Implications for Alzheimer's disease treatments and clinical up date. In: Giacobini, E., Becker, R. (Eds.), Alzheimer's Disease: Therapeutic Strategies, Birkhauser, Boston, MA, pp. 219-223.
3. Giacobini E. From molecular structure to Alzheimer therapy. Jpn. J. Pharmacol. 74:1997;225-241.
4. Gilbert D.G. Depression, smoking, and nicotine: toward a bioinformational situation by trait model. Drug Dev. Res. 38:1996;267-277.
5. Honma A., Miyamoto M. ACh and ACh E inhibitor. Jpn. J. Neuropharmacol. 16:1994;729-738.
6. Krug M., Brödemann R., Ott T. Identical responses of the two hippocampal theta generators to physiological and pharmacological activation. Brain Res. Bull. 6:1981;5-11.
7. Kumar, V., 1994. Introduction to cholinesterase inhibitors used in Alzheimer's disease therapy. In: Giacobini, E., Becker, R. (Eds.), Alzheimer's Disease: Therapeutic Strategies. Birkhauser, Boston, pp. 99-102.
8. Levin E.D., Conners C.K., Sparrow E., Hinton S.C., Erhardt D., Meck W.H., Rose J.E., March J. Nicotine effects on adults with attention-deficit/hyper activity disorder. Psychopharmacology. 123:1996;55-63.
9. Newhouse P., Potter A., Corwin J. Effects of cholinergic agents on cognitive functioning in Alzheimer's and Parkinson's disease. Drug. Dev. Res. 38:1997;278-289.
10. Ott T., Malisch R., Destrade C. Evidence for transmitter-specific modulation of slow, rhythmic activity of the hippocampus. Biomed. Biochim. Acta. 42:1983;967-979.
11. Sawyer H.W., Everret J.W., Green J.D. The rabbit diencephalone in stereotaxic coordinates. J. Comp. Neurol. 101:1954;801-824.
12. Yamamoto, J., 1989. EEG power spectra and brain function. In: Meyer, E.M., Simpkins, J.W., Yamamoto, J. (Eds.), Novel Approaches to the Treatment of Alzheimer's Disease. Plenum Publishing, New York, NY, pp. 329-345.
13. Yamamoto J. Cortical and hippocampal EEG power spectra in animal models of schizophrenia produced with methamphetamine, cocaine, and phencyclidine. Psychopharmacology. 131:1997;379-387.
14. Yamamoto J. Relationship between hippocampal theta-wave frequency and emotional behaviors in rabbits produced with stresses or psychotropic drugs. Jpn. J. Pharmacol. 76:1998;125-127.